Histologically Malignant Solitary Fibrous Tumour of the Anterior Thoracic Wall: A Case Report and Review of the Literature by Archontaki, Maria et al.
Hindawi Publishing Corporation
Case Reports in Medicine
Volume 2010, Article ID 257167, 4 pages
doi:10.1155/2010/257167
Case Report
Histologically Malignant Solitary FibrousTumourof the Anterior
Thoracic Wall: A Case Reportand Reviewof the Literature
Maria Archontaki,1 DimitrisP.Korkolis,2 Niki Arnogiannaki,3 SteliosHatzijiannis,1
PanagiotisDendrinos,1 Christos Megapanos,1 DimitrisKassotakis,1 andGeorgiosKokkalis1
1Department of Plastic and Reconstructive Surgery, Greek Anticancer Institute, St. Savvas Hospital,
171 Alexandras Avenue, 115 22 Athens, Greece
2Department of Surgery, Greek Anticancer Institute, St. Savvas Hospital, 171 Alexandras Avenue, 115 22 Athens, Greece
3Department of Pathology, Greek Anticancer Institute, St. Savvas Hospital, 171 Alexandras Avenue, 115 22 Athens, Greece
Correspondence should be addressed to Maria Archontaki, marchontaki@web.de
Received 10 February 2010; Revised 16 April 2010; Accepted 13 May 2010
Academic Editor: Herman Terence Yee
Copyright © 2010 Maria Archontaki et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Solitary ﬁbrous tumour (SFT) is a rare oncological entity that most often arises in the pleura. Over the past 10 years, the tumour
has been described at numerous extrapleural locations. We present the case of a 42-year-old female Caucasian patient with an
extrapleural SFT located at the anterior thoracic wall for 22 years, with atypical histological characteristics and clinical features of
malignancy. Management consisted of a wide surgical resection, plastic reconstruction, and postoperative radiotherapy. Although
extrapleural SFT usually behaves as a benign soft tissue tumour, it can also present with a more aggressive local behavior, including
locoregional recurrence or metastasis. In that case, a multidisciplinary approach is required for accurate diagnosis and proper
management.
1.Introduction
Extrapleural SFTs account for 0.6% of all soft tissue tumours
[1]. Malignant extrapleural SFT is an even more rare neo-
plasmandhasbeendescribedonlyinlimitedseries[2,3]and
case reports [4–6]. In a large case series of SFTs, Gold et al.
[1] reported that no diﬀerence exists between intrathoracic
SFT and extrapleural SFT regarding rates of malignant pat-
hological features but extrapleural SFTs had a signiﬁcantly
higher rate of locoregional recurrence suggesting a more
aggressive clinical behavior. In a more recent study of Cra-
nshawetal.[7]55%ofextrapleuralSFTsofthisseriesshowed
malignant features.
We hereby present the unusual case of a 42-year-old
patient presented with a large, histologically malignant SFT
of the anterior thoracic wall.
2.CaseReport
A 42-year-old female, Caucasian, patient was referred to
our institute suﬀering from a large, pedicled, painless, slow-
growing mass, located on the anterior thoracic wall. In addi-
tion the patient was complaining of fatigue and weakness for
the past 3 months. The lesion developed as a long-standing
tumourwithdurationofapproximately22years.Therewasa
history of incomplete previous resection of the tumour twice
in the past, resulting in locoregional recurrence. The tumour
was diagnosed according to the ﬁrst histological report as
a dermatoﬁbrosarcoma protuberance (DFSP) and according
to the second one as a hemangiopericytoma. In addition to
recurrence, neglect on the part of patient, patient’s fear, and
embarrassment for her disease may have played a role in the
development of this chronic large tumour.
On physical examination, the tumour appeared as
an exophytic pseudolobulated tan-pink mass, measur-
ing 18 × 10cm, with multiple hemorrhagic foci, yellow
and black necrosis, and localized infection with purulent
exudates (Figure 1). There was no evidence of regional
lymph node involvement. Laboratory examination revealed
hypochromic microcytic anemia with hemoglobin serum
level of 5.2mg/dl, probably due to the intermittent bleeding
of the tumour. The iron-deﬁciency anemia was relieved with2 Case Reports in Medicine
Figure 1: Solitary ﬁbrous tumour of the anterior thoracic wall.
Figure 2: Tumour specimen after resection.
the administration of 2 blood units. Magnetic Resonance
Imaging (MRI) studies revealed no bone or cartilaginous
involvement, apart from the chest wall soft tissue inﬁltration.
The additional studies, including chest X-ray and abdominal
ultrasound that were performed, were unremarkable with no
evidence of metastatic disease.
Because of the high vascularity of the tumour prior to
incisionalbiopsy,apreoperativeselectiveembolizationofthe
right internal thoracica artery was performed in order to
reduce vascularity and minimize intraoperative hemorrhage.
The patient underwent wide local resection of the tumour by
a surgical team consisting of thoracic and plastic surgeons
(Figure 2). For the reconstruction of the wide defect both
pectoralis major advancement ﬂaps were mobilized and
covered with a partial-thickness skin graft (Figure 3).
The histological examination of the biopsy and resection
specimen revealed a spindle cell tumour with strong diﬀuse
CD34, Bcl-2, and vimentin positivity but negativity for
S-100, c-kit, smooth muscle actin, and cytokeratin (AE1
+ AE3). Immunohistochemically, the tumour cells were
stained also negative with CD99. Microscopically spin-
dle cells were arranged patternless, with a characteristic
hemangiopericytoma-like morphology, and there were areas
Figure 3: Immediate postoperative result after tumour resection
and reconstruction with bilateral pectoralis major advancement
ﬂaps and split-thickness skin graft.
Figure 4: Malignant solitary ﬁbrous tumour demonstrating pat-
ternless arrangement of spindle cells and areas with very high
cellularity. The spindle cells have moderate cytological atypia, and
three mitoses in mitotically active ﬁelds are evident (HE x400).
with very high cellularity (Figures 4 and 5). The spindle
cells had moderate cytologic atypia and 9 mitoses per
10HPFs. Foci of superﬁcial necrosis were also identiﬁed
(coagulative tumour necrosis). The tumour appeared cen-
tered on subcutaneous tissues. Surgical resection margins
were not involved. The diagnosis of histologically malignant
extrapleural SFT was conﬁrmed. The diﬀerential diagno-
sis of this tumour, in particular, exclusion of a DFSP—
tumour’s original diagnosis—was made on the basis of its
characteristic microscopic appearance in conjunction with
immunohistochemical features. Histologically, SFTs present
a typical, although not diagnostic, hemangiopericytoma-like
morphology with patternless arrangement of spindle cells in
a collagenous background whereas DFSPs are characterized
mostly by a storiform pattern. In addition, DFSP stains
frequently positive for CD34 but negative for Bcl-2.
Postoperatively the patient received adjuvant radio-
therapy (Intensity-Modulated Radiation Therapy) and wasCase Reports in Medicine 3
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Figure 5: (a) Malignant solitary ﬁbrous tumour demonstrating uniform immunoreactivity for CD34 (CD34 x400) with
hemangiopericytoma-like morphology. (b) A hyalinized vessel with thrombus in it is evident (HE x200), as well as (c) hyalinized staghorn
vessels of tumour, that are centered (CD34 x200). (d) Areas of hypo- and hypercellularity (HE x200) are evident.
closely followed up. In the ensuing 12 months after surgery
and radiation treatment, the patient has remained asymp-
tomatic and without clinical or radiological evidence of
recurrence or distant metastasis.
3. Discussion
SFT is an uncommon neoplasm of mesenchymal origin that
was ﬁrst recognized by Klemperer and Rabin as a distinctive
pleural lesion in 1931 [8]. Over the last 10 years, at least
106 extrapleural SFTs have been reported, located in the
meninges, orbit, upper respiratory tract, salivary glands,
thyroid, peritoneum, liver, retroperitoneum, adrenal gland,
kidney, spermatic cord, urinary bladder and prostate spinal
cord, periosteum, and soft tissue mainly in the head and
neck [1–7, 9–15]. About 10%–36% of intrathoracic SFTs are
histologically or clinically malignant while malignant SFTs
have been described in 11%–33% of cases at other locations
[2, 3]. To the best of our knowledge, this is the ﬁrst case
report of a histologically malignant extrapleural SFT located
on the anterior thoracic wall.
Because of the overlapping of histological diagnosis of
SFT with other soft tissue tumours, its correct and precise
pathological characterization necessitates experienced soft
tissuepathologiststoevaluatethespecimenbothforaproper
diagnosis as well as for the detection of malignant features.
The diﬀerential diagnosis is based on the microscopical mor-
phology (WHO 2003 criteria: patternless growth pattern,
composed of round to spindle-shaped ﬁbroblastic cells set in
a collagenous matrix, hemangiopericytoma-like vasculature
pattern often hyalinized thickened vessel walls) and charac-
teristic immunohistochemical ﬁndings -positivity for CD34,
Bcl-2, CD99, and vimentin [11]. The diﬀerential diagnosis
is extensive including hemangiopericytoma, synovial sar-
coma, dermatoﬁbrosarcoma protuberans, leiomyosarcoma,
liposarcoma, and malignant peripheral nerve sheath tumour
[10, 11].
SFTs may present malignant behavior with local recur-
rence or metastasis, and there exist well-established patho-
logical criteria of malignancy [14]. Vallat-Decouvelaere et al.
[2] suggested atypical histological features, such as nuclear
atypia, areas of increased cellularity, necrosis, and 4 or
more mitoses per 10 high-power microscopic ﬁelds, as being
predictive for clinical malignant behavior of the tumour and
found local or distant relapse in those cases in 80%. In
addition, according to Gold et al. [1] primary tumour size
of more than 10cm and positive surgical resection margins
are positively correlated with unfavorable clinical outcome.
In the studies of Vallat-Decouvelaere et al. [2]a n dG o l d
et al. [1] local recurrence appears in 4.3% and 6.7% and
metastasis in 5.4% and 5.3%, respectively. Local recurrence
or metastasis occurs most often within the ﬁrst 2 years,
while the sites of distant metastasis are most commonly the
lung and the liver. Occasionally benign SFTs behave in a4 Case Reports in Medicine
clinically malignant fashion particularly after a long period
of time from the original tumour [1] .Am o r er e c e n tl a r g e
series of extrapleural SFTs (ESFTs) with a long follow-up
period reported by Cranshaw et al. [7] showed that ESFTs
behave clinically in a manner similar to high-grade soft
tissue sarcoma with relatively high rates of local recurrence
(16.2%) and metastatic spread (8.9%) as well as with a
poor overall prognosis (5-year survival rate 40%). Although
presence of malignant histopathological features remains an
indicator of a poor clinical outcome for these cases, no ESFT
should be considered deﬁnitely benign currently. It should
be emphasized that the fact that histologic appearance does
not correlate perfectly with the clinical behavior in SFT is a
factofmajorclinicalimportance.Occasionally,histologically
benign ESFTs are clinically malignant while many histo-
logically malignant ESFTs are clinically benign. Therefore,
extended follow-up is necessary to identify and manage the
relatively high rate of recurrent disease [7]. It is clear that
in the case of the presented patient, incomplete primary
resections accounted for early locoregional recurrence.
The treatment of choice for extrapleural SFT that is
widelyacceptediscompletesurgicalextirpationwithdisease-
free margins. Adjuvant radiation therapy and chemotherapy
may be used especially in malignant variants of the disease or
incomplete resections with no further surgical options. Due
to the late recurrence or metastasis that may appear in the
case of an SFT, an extended follow-up surveillance should be
advised [1, 2, 11].
4. Conclusion
The behavior of SFT is unpredictable [14]. The risk of local
r e c u r r e n c ea n dm e t a s t a s i si sh i g he v e ni ns o - c a l l e d“ b e n i g n ”
tumours after a long period of time. Tumour specimens
should be evaluated by experienced soft tissue pathologists.
The treatment of choice is complete resection followed by
extended follow-up surveillance [11].
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